Forte Biosciences (FBRX) EPS (Basic) Growth (1y) (2017 - 2026)
Forte Biosciences (FBRX) EPS (Basic) Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | 9.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.64% |
| Dec 31, 2025 | 34.38% |
| Sep 30, 2025 | 57.07% |
| Jun 30, 2025 | 69.90% |
| Mar 31, 2025 | 67.67% |
| Dec 31, 2024 | 49.79% |
| Sep 30, 2024 | 30.57% |
| Jun 30, 2024 | 35.74% |
| Mar 31, 2024 | 48.44% |
| Dec 31, 2023 | 29.46% |
| Sep 30, 2023 | -45.11% |
| Jun 30, 2023 | -97.56% |
| Mar 31, 2023 | -72.66% |
| Dec 31, 2022 | 68.80% |
| Sep 30, 2022 | 69.67% |
| Jun 30, 2022 | 89.68% |
| Mar 31, 2022 | -8,590.11% |
| Dec 31, 2021 | 33.91% |
| Sep 30, 2021 | -15,052.26% |
| Jun 30, 2021 | -18,337.24% |